Cerium-Tannic Acid Nanoparticle Incorporated Hyaluronate Gel for Enhanced Anti-Vascular Endothelial Growth Factor Efficacy in Choroidal Neovascularization
ACS Applied Nano Materials · 20.11.2026
DOI: 10.1021/acsanm.6c05447 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 20.11.2026. Verfasst von Jiayi Wei und 12 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Science and Technology Department of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Anti-vascular endothelial growth factor (anti-VEGF) therapy is the main treatment for choroidal neovascularization (CNV) in wet age-related macular degeneration (wAMD). However, its efficacy is often diminished in the complex pathological microenvironment, such as hypoxia, oxidative stress, and chronic inflammation. These factors affect VEGF overexpression through hypoxia-inducible factor-1α (HIF-1α) stabilization, thereby inducing drug resistance. To address this, Cerium@Tannic acid (Ce-TA) and aflibercept were encapsulated in sodium hyaluronate gel to form HA@Ce-TA@aflibercept (HCeAf). Characterizations reveal that HCeAf forms a hierarchical porous nanonetwork architecture, with homogeneous distribution of C, N, O, S, and Ce elements throughout the gel matrix. Rheological tests confirm that HCeAf hydrogel maintains stable elastic modulus (G′) across a wide strain and frequency range and exhibits shear-thinning viscosity behavior, which is favorable for intraocular administration. The HCeAf gel showed favorable biocompatibility. In the CNV model, HCeAf exerted a potent anti-inflammatory effect via modulating the levels of pro-inflammatory and anti-inflammatory cytokines. Importantly, the Ce-TA in HCeAf not only effectively scavenged reactive oxygen species (ROS) but also catalyzed the decomposition of H2O2 into O2, thereby alleviating hypoxia. This comprehensive microenvironment modulation significantly enhanced the therapeutic effect of aflibercept, suppressing neovascularization and leakage. This work demonstrates that the HCeAf platform synergistically enhances the therapeutic efficacy of aflibercept via scavenging ROS, generating oxygen, and modulating the inflammatory microenvironment to inhibit the activation of HIF-1α. This study offers a promising approach to overcome the limitations of anti-VEGF monotherapy for CNV.
Förderung
- Natural Science Foundation of Hebei Province
- Science and Technology Department of Zhejiang Province
- National Natural Science Foundation of China
- Ningbo Top Medical and Health Research Program
Zitieren
APA
Wei, J., Shang, X., Xiaokaiti, N., Guo, H., Li, M., Yi, Q., Chen, P., Hua, C., Zhou, X., Lu, D., Zhang, Z., Yao, J., & Tong, L. (2026). Cerium-Tannic Acid Nanoparticle Incorporated Hyaluronate Gel for Enhanced Anti-Vascular Endothelial Growth Factor Efficacy in Choroidal Neovascularization. ACS Applied Nano Materials. https://doi.org/10.1021/acsanm.6c05447
Vancouver
Wei J, Shang X, Xiaokaiti N, Guo H, Li M, Yi Q, et al. Cerium-Tannic Acid Nanoparticle Incorporated Hyaluronate Gel for Enhanced Anti-Vascular Endothelial Growth Factor Efficacy in Choroidal Neovascularization. ACS Applied Nano Materials. 2026. doi:10.1021/acsanm.6c05447
BibTeX
@article{Wei2026,
author = {Wei, Jiayi and Shang, Xunjie and Xiaokaiti, Naiyila and Guo, Huanhuan and Li, Ming and Yi, Quanyong and Chen, Pingping and Hua, Chaoqun and Zhou, Xinzhe and Lu, Dasheng and Zhang, Zongduan and Yao, Jingke and Tong, Liyang},
title = {Cerium-Tannic Acid Nanoparticle Incorporated Hyaluronate Gel for Enhanced Anti-Vascular Endothelial Growth Factor Efficacy in Choroidal Neovascularization},
journal = {ACS Applied Nano Materials},
year = {2026},
doi = {10.1021/acsanm.6c05447}
}
EUVIMED